Biscaglia, Simone

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 4.

Journal Article

Landi, Antonio; Gargiulo, Giuseppe; Esposito, Giovanni; Campo, Gianluca; Biscaglia, Simone; Heg, Dik; Valgimigli, Marco (2024). Does morphine attenuate the Inhibition of Platelet Aggregation for both oral and parenteral P2Y12 inhibitors? Thrombosis research, 237, pp. 31-33. Elsevier 10.1016/j.thromres.2024.03.015

Piccolo, Raffaele; Calabrò, Paolo; Varricchio, Attilio; Baldi, Cesare; Napolitano, Giovanni; De Simone, Ciro; Mauro, Ciro; Stabile, Eugenio; Caiazzo, Gianluca; Tesorio, Tullio; Boccalatte, Marco; Tuccillo, Bernardino; Bottiglieri, Giuseppe; Russolillo, Enrico; Lorenzo, Emilio Di; Carrara, Greta; Cassese, Salvatore; Leonardi, Sergio; Biscaglia, Simone; Costa, Francesco; ... (2023). Rationale and Design of the PARTHENOPE Trial: A Two-by-Two Factorial Comparison of Polymer-Free vs. Biodegradable-Polymer Drug-Eluting Stents and Personalized vs. Standard Duration of Dual Antiplatelet Therapy in All-Comers Undergoing PCI. American Heart Journal, 265, pp. 153-160. Elsevier 10.1016/j.ahj.2023.08.001

Spitaleri, Giosafat; Tebaldi, Matteo; Biscaglia, Simone; Westra, Jelmer; Brugaletta, Salvatore; Erriquez, Andrea; Passarini, Giulia; Brieda, Alessandro; Leone, Antonio Maria; Picchi, Andrea; Ielasi, Alfonso; Girolamo, Domenico Di; Trani, Carlo; Ferrari, Roberto; Reiber, Johan H C; Valgimigli, Marco; Sabatè, Manel; Campo, Gianluca (2018). Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease. Circulation: Cardiovascular interventions, 11(2), e006023. Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.117.006023

Gargiulo, Giuseppe; Costa, Francesco; Ariotti, Sara; Biscaglia, Simone; Campo, Gianluca; Esposito, Giovanni; Leonardi, Sergio; Vranckx, Pascal; Windecker, Stephan; Valgimigli, Marco (2016). Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial. American Heart Journal, 174, pp. 95-102. Elsevier 10.1016/j.ahj.2016.01.015

This list was generated on Sat Dec 21 17:48:37 2024 CET.
Provide Feedback